Fonti:WHO, Our World in Data, World Bank
Le traduzioni sono principalmente generate dall'IA. Verranno aggiornate nel tempo.
112 rispondenti di gruppi di pazienti provenienti da Brasile ci hanno informato su come interagiscono e collaborano con le autorità regolatorie dei farmaci per garantire un accesso equo o più accessibile ai medicinali.
65% dei rispondenti da Brasile rappresenta "Regolarmente" o "A volte" gli interessi dei pazienti presso le autorità regolatorie dei farmaci.
Numero totale di pazienti raggiunti = ~597.300
Pazienti raggiunti da ciascun gruppo di pazienti (64 rispondenti).
ANNABRA [Associação Nanismo Brasil – Associazione per il Nanismo del Brasile] — rappresenta gli interessi delle persone che vivono con il nanismo e delle loro famiglie in una serie di contesti istituzionali e forum di politica pubblica. L'associazione partecipa alle consultazioni pubbliche e monitora i processi di valutazione delle tecnologie sanitarie (HTA) condotti dagli organismi di regolamentazione responsabili delle raccomandazioni sul rimborso e sull'accesso ai farmaci.
Gruppo nazionale di pazienti con disturbi della crescita
ABEM [Associação Brasileira de Esclerose Múltipla – Associazione Brasiliana per la Sclerosi Multipla] svolge un ruolo attivo nella rappresentanza istituzionale delle persone che vivono con la sclerosi multipla in Brasile, interagendo con gli organi di regolamentazione, le autorità governative e i forum di politica pubblica su questioni relative all'accesso ai trattamenti. In questa veste, l'organizzazione partecipa a una serie di attività di advocacy e di coinvolgimento istituzionale, tra cui…
Gruppo di pazienti con patologie neurologiche nazionali
ABEM [Associação Brasileira de Esclerose Múltipla – Associazione Brasiliana per la Sclerosi Multipla] svolge un ruolo attivo nella rappresentanza istituzionale delle persone che vivono con la sclerosi multipla in Brasile, interagendo con gli organi di regolamentazione, le autorità governative e i forum di politica pubblica su questioni relative all'accesso ai trattamenti. In questa veste, l'organizzazione partecipa a una serie di attività di advocacy e di coinvolgimento istituzionale, tra cui: • elaborazione di note tecniche, corrispondenza istituzionale formale e dichiarazioni di posizione ufficiali a sostegno dell'accesso equo ai trattamenti; politiche.
Gruppo di pazienti con patologie neurologiche nazionali
L'organizzazione si batte per i diritti dei pazienti affetti da malattie reumatiche e autoimmuni, fornendo orientamento sull'accesso ai trattamenti attraverso il SUS [Sistema Único de Saúde – Sistema Sanitario Unificato], facilitando il dialogo con i professionisti sanitari e sostenendo iniziative di sensibilizzazione e sforzi di politica pubblica incentrati sulle esigenze dei pazienti.
A organização atua na defesa dos direitos dos pacientes com doenças reumáticas e autoimunes, promovendo orientação sobre acesso a tratamentos pelo SUS, diálogo com profissionais de saúde e participação em iniciativas de conscientização e políticas públicas voltadas aos pacientes.
Gruppo locale di pazienti con malattie reumatiche
Le percentuali seguenti evidenziano come i 73 gruppi di pazienti interagiscono con le autorità regolatorie e si fanno portavoce degli interessi dei pazienti. Poiché i partecipanti possono essere rappresentati in più di un'area, le percentuali potrebbero non totalizzare il 100%.
| Testo in inglese | Area terapeutica | Categoria | Pazienti raggiunti | Copertura geografica | Coinvolgimento normativo | Rispondente |
|---|---|---|---|---|---|---|
| Public consultations, public hearings, advocacy events, national and international forums. | Cancro > Cancro: altro | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 10.000 | National | Sometimes | 119017268057 |
| Representation of patients with SMA [Spinal Muscular Atrophy] at the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS - National Commission for the Incorporation of Technologies in the SUS (Brazilian Public Health System)] meeting held in December 2025; submission of responses and recommendations to CONITEC's preliminary reports on the reimbursement of SMA treatments; and mobilisation of public participation in open consultations. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 5000 | National | Regularly | 119042861822 |
| Engagement with ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], through the commissions of the National Health Council, on behalf of ADB [Associação de Doentes de Behçet - Behçet’s Disease Patients Association]. | Neuromuscolare > Distrofia muscolare | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 100 | Regional | Regularly | 119045134485 |
| CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency], ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency], Ministry of Health, and others. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 5000 | National | Regularly | 119046302524 |
| Participation in advisory councils, forums, and public manifestos. | Sanguinamento > Emofilia | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 1000 | Regional | Regularly | 119052656211 |
| We participate in COSAÚDE [Comitê Permanente de Regulação da Atenção à Saúde - Permanent Committee for Healthcare Regulation] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Respiratorio > Asma e BPCO | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 10.000 | National | Regularly | 119073295628 |
| We maintain partnerships with the Public Prosecutor's Office, the Public Defender's Office, the State Department of Health, municipal health secretariats, and other institutions that can support the procurement and/or approval of medications. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 10.000 | Regional | Sometimes | 119077778824 |
| We engage with government bodies in forums where matters relating to our cause are discussed. | Sanguinamento > Disturbi emorragici: la maggior parte dei tipi | Partenariato normativo > Collaborazione con gli organismi di regolamentazione | 100.000 | National | Regularly | 119083316815 |
| Both within representative bodies and among regulators such as CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Cancro > Cancro: la maggior parte dei tipi | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100 | National | Sometimes | 115043432408 |
| Meetings at the Ministry of Health, ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency], and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Cancro > Cancro: altro | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | National | Sometimes | 119017268057 |
| CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 1000 | National | Sometimes | 119025216545 |
| We have contributed to the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] public consultations relating to oncology, through FEMAMA [Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama – Brazilian Federation of Philanthropic Institutions Supporting Breast Health]. | Cancro > Cancro: la maggior parte dei tipi | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | Local | Rarely | 119042830466 |
| Patient representation at the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] meeting held in December 2025. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 5000 | National | Regularly | 119042861822 |
| Representation of patients with SMA [Spinal Muscular Atrophy] at the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS - National Commission for the Incorporation of Technologies in the SUS (Brazilian Public Health System)] meeting held in December 2025; submission of responses and recommendations to CONITEC's preliminary reports on the reimbursement of SMA treatments; and mobilisation of public participation in open consultations. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 5000 | National | Regularly | 119042861822 |
| Engagement with ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], through the commissions of the National Health Council, on behalf of ADB [Associação de Doentes de Behçet - Behçet’s Disease Patients Association]. | Neuromuscolare > Distrofia muscolare | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100 | Regional | Regularly | 119045134485 |
| Our organisation is a member of the Advisory Board of INCA [Instituto Nacional de Câncer – National Cancer Institute] (CONSINCA [Conselho Consultivo do INCA – Advisory Board of INCA]), CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], and COSAÚDE [Comitê de Saúde Suplementar -Supplementary Health Committee]. | Cancro > Cancro: sangue | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | National | Regularly | 119046062542 |
| CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency], ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency], Ministry of Health, and others. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 5000 | National | Regularly | 119046302524 |
| Direct meetings with the division of the Ministry of Health responsible for rare disease care, formal communications addressed directly to SECTICS [Secretaria de Ciência, Tecnologia, Inovação e do Complexo Econômico-Industrial da Saúde - Secretariat of Science, Technology, Innovation and the Health Economic-Industrial Complex] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100 | National | Regularly | 119051551373 |
| CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] meetings, Health Committees and Councils, and the Blood and Blood Products Coordination. | Sanguinamento > Disturbi emorragici: la maggior parte dei tipi | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | National | Regularly | 119054614432 |
| Participation in a rotating seat on CINITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], representing civil society in proceedings No. 23/2025 and No. 39/2025. | Respiratorio > Respiratorio: la maggior parte delle condizioni | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | Do not know | National | Sometimes | 119063788854 |
| We are active in discussions on the incorporation of therapies into the SUS [Sistema Único de Saúde — Brazil's Unified Health System], access to high-cost medicines. | Disabilità visiva > Disabilità visiva | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 1000 | National | Regularly | 119065385473 |
| Response to requests submitted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | HIV > HIV | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 1000 | Local | Rarely | 119069127920 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged in… monitoring and contributing to public consultations on the incorporation of medicines and health technologies. | Neurologico > Sclerosi multipla | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | National | Regularly | 119073066358 |
| ABEM (Associação Brasileira de Esclerose Múltipla — the Brazilian Multiple Sclerosis Association) plays an active role in the institutional representation of people living with multiple sclerosis in Brazil, engaging with regulatory bodies, government authorities, and public policy forums on issues related to treatment access. In this capacity, the organisation participates in a range of advocacy and institutional engagement activities, including: • monitoring and contributing to public consultations on the incorporation of medicines and health technologies. | Neurologico > Sclerosi multipla | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | National | Regularly | 119073066358 |
| Vosoritide [for achondroplasia], a medication currently under evaluation by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Endocrino > Disturbi della crescita | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 1000 | National | Regularly | 119073115381 |
| We participate in COSAÚDE [Comitê Permanente de Regulação da Atenção à Saúde - Permanent Committee for Healthcare Regulation] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Respiratorio > Asma e BPCO | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 10.000 | National | Regularly | 119073295628 |
| The organization participates actively in public hearings held by the ANS (Agência Nacional de Saúde Suplementar — Brazil's National Supplementary Health Agency) and the National Congress, as well as in public consultations convened by the ANS and CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS — National Committee for Health Technology Incorporation in the Unified Health System), and contributes to the National Health Council through the seat held by Biored Brasil, an organization co-founded by AME [Amigos Múltiplos pela Esclerose - Multiple Friends for Sclerosis] , among others. The organiSation further acts as a proponent of solutions it considers to be structural in nature, directing strategies that connect all of the aforementioned bodies through the drafting of legislative bills, technical briefs, and supplementary documents intended to support — within AME's remit — the Health Technology Assessment (HTA) process in Brazil. | Neurologico > Sclerosi multipla | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100.000 | National | Regularly | 119073437945 |
| Activities range from participation in public consultations held by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and the ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. | Cronico > Malattie croniche in generale | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100.000 | National | Regularly | 119074690098 |
| Our engagement spans from participation in public consultations — including those conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. Our social oversight and mobilisation efforts are conducted strategically and also include direct engagement with regulatory authorities. | Cronico > Malattie croniche in generale | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100.000 | National | Regularly | 119074690098 |
| We are continuously engaged in meetings with bodies such as Anvisa [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency] and the Ministry of Health [in Brazil], and we actively participate in public consultations conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 1000 | Regional | Sometimes | 119077444348 |
| ANNABRA — Associação Nanismo Brasil [Brazilian Dwarfism Association] — represents the interests of individuals living with dwarfism and their families across a range of institutional settings and public policy forums. The association participates in public consultations and monitors health technology assessment (HTA) processes conducted by the regulatory bodies responsible for recommendations on the reimbursement and access to medicines. | Endocrino > Disturbi della crescita | Partenariato normativo > Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 1000 | National | Regularly | 119078211127 |
| We support the registration of medicines. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Contribuire alle presentazioni per l'Autorizzazione all'Immissione in Commercio | 100 | Regional | No | 119078233817 |
| Meetings at the Ministry of Health, ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency], and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Cancro > Cancro: altro | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 10.000 | National | Sometimes | 119017268057 |
| Patient representation at the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] meeting held in December 2025. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 5000 | National | Regularly | 119042861822 |
| Direct meetings with the division of the Ministry of Health responsible for rare disease care. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 100 | National | Regularly | 119051551373 |
| Participation in councils and forums; endorsement of position statements; mobilisation of parliamentarians; submission of legislative proposals and regulatory recommendations; and engagement of public opinion and regulatory authorities. | Sanguinamento > Emofilia | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 1000 | Regional | Regularly | 119052656211 |
| CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] meetings, Health Committees and Councils, and the Blood and Blood Products Coordination. | Sanguinamento > Disturbi emorragici: la maggior parte dei tipi | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 10.000 | National | Regularly | 119054614432 |
| ABEM (Associação Brasileira de Esclerose Múltipla — the Brazilian Multiple Sclerosis Association) plays an active role in the institutional representation of people living with multiple sclerosis in Brazil, engaging with regulatory bodies, government authorities, and public policy forums on issues related to treatment access. In this capacity, the organisation participates in a range of advocacy and institutional engagement activities, including: • monitoring and contributing to public consultations on the incorporation of medicines and health technologies; • participating in public hearings and technical meetings with government bodies and institutions within the healthcare system; • institutional engagement with bodies such as the Ministry of Health, ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency], and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], particularly on matters relating to medicine access, clinical protocols, and dispensing policies; • engagement with the Public Prosecutor's Office, Public Defenders' Offices, and other social oversight bodies in cases of access barriers or medicine supply shortages; | Neurologico > Sclerosi multipla | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 10.000 | National | Regularly | 119073066358 |
| The organisation participates actively in public hearings held by the ANS (Agência Nacional de Saúde Suplementar — Brazil's National Supplementary Health Agency) and the National Congress, as well as in public consultations convened by the ANS and CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS — National Committee for Health Technology Incorporation in the Unified Health System), and contributes to the National Health Council through the seat held by Biored Brasil, an organization co-founded by AME [Amigos Múltiplos pela Esclerose - Multiple Friends for Sclerosis] , among others. The organisation further acts as a proponent of solutions it considers to be structural in nature, directing strategies that connect all of the aforementioned bodies through the drafting of legislative bills, technical briefs, and supplementary documents intended to support — within AME's remit — the Health Technology Assessment (HTA) process in Brazil. | Neurologico > Sclerosi multipla | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 100.000 | National | Regularly | 119073437945 |
| Our engagement spans from participation in public consultations — including those conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. Our social oversight and mobilisation efforts are conducted strategically and also include direct engagement with regulatory authorities. | Neurologico > Sclerosi multipla | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 100.000 | National | Regularly | 119074690047 |
| … Strategic social oversight and mobilisation efforts also encompass dialogue with regulatory bodies. | Cronico > Malattie croniche in generale | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 100.000 | National | Regularly | 119074690098 |
| We are continuously engaged in meetings with bodies such as Anvisa [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency] and the Ministry of Health [in Brazil], and we actively participate in public consultations conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Raro > Malattie rare: la maggior parte dei tipi | Partenariato normativo > Partecipare/facilitare riunioni con responsabili politici/regolatori | 1000 | Regional | Sometimes | 119077444348 |
| We hold seats on the Municipal Health Council of Salvador, the State Health Council of Bahia, and the National Health Council, through FEMAMA [Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama – Brazilian Federation of Philanthropic Institutions Supporting Breast Health]. | Cancro > Cancro: la maggior parte dei tipi | Partenariato normativo > Con altri sostenitori della salute | 5000 | Local | Regularly | 119021005578 |
| We have contributed to the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] public consultations relating to oncology, through FEMAMA [Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama – Brazilian Federation of Philanthropic Institutions Supporting Breast Health]. | Cancro > Cancro: la maggior parte dei tipi | Partenariato normativo > Con altri sostenitori della salute | 10.000 | Local | Rarely | 119042830466 |
| Engagement with ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], through the commissions of the National Health Council, on behalf of ADB [Associação de Doentes de Behçet - Behçet’s Disease Patients Association]. | Neuromuscolare > Distrofia muscolare | Partenariato normativo > Con altri sostenitori della salute | 100 | Regional | Regularly | 119045134485 |
| The organisation participates actively in public hearings held by the ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency] and the National Congress, as well as in public consultations convened by the ANS and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], and in the National Health Council (through the seat held by Biored Brasil, an organisation co-founded by AME [Amigos Múltiplos pela Esclerose -Multiple Friends for Sclerosis], among other organisations. | Neurologico > Sclerosi multipla | Partenariato normativo > Con altri sostenitori della salute | 100.000 | National | Regularly | 119073437945 |
| We participate actively in decision-making bodies, conducting advocacy work with the legislature and government secretariats. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 5000 | National | Regularly | 119045358161 |
| Participation in councils and forums; endorsement of position statements; mobilisation of parliamentarians; submission of legislative proposals and regulatory recommendations; and engagement of public opinion and regulatory authorities. | Sanguinamento > Emofilia | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 1000 | Regional | Regularly | 119052656211 |
| We advocate for public policies, access, treatment, updates, and so forth. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 5000 | National | Regularly | 119055145819 |
| We work alongside legislators to drive improvements and advance bills that serve the interests of patients. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 1000 | National | Regularly | 119072208647 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged in the institutional representation of people living with multiple sclerosis in Brazil, maintaining dialogue with regulatory bodies, governmental authorities, and forums involved in the formulation of public policies related to treatment access. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 10.000 | National | Regularly | 119073066358 |
| The organisation advocates for the rights of patients living with rheumatic and autoimmune diseases, providing guidance on access to treatments through the SUS [Sistema Única de Saúde – Unified Health System], facilitating dialogue with healthcare professionals, and supporting awareness initiatives and public policy efforts focused on patient needs. | Reumatico > Malattie reumatiche: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 1000 | Local | Sometimes | 119074685227 |
| … Strategic social oversight and mobilisation efforts also encompass dialogue with regulatory bodies. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 100.000 | National | Regularly | 119074690047 |
| Through our presence in Brasília — engaging with health authorities and the National Congress in the development and defence of public health policies. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 5000 | National | Regularly | 119074846445 |
| ANNABRA [Associação Nanismo Brasil -Brazil Dwarfism Association] advocates on behalf of individuals living with dwarfism and their families across a range of institutional settings and public policy forums. | Endocrino > Disturbi della crescita | Influenzare le politiche e la legislazione > Influenzare le politiche sanitarie e la legislazione | 1000 | National | Regularly | 119078211127 |
| Public consultations; public hearings. | Cancro > Cancro: altro | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 10.000 | National | Sometimes | 119017268057 |
| Through mobilisation efforts and active participation in public calls, public consultations, and public hearings. | Cancro > Cancro: ginecologico | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | National | Regularly | 119021190367 |
| Participating in the development of public policies and in meetings concerning the incorporation of medicines. | Neurodegenerativo > Alzheimer | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 5000 | National | Regularly | 119037286447 |
| Representation of patients with SMA [Spinal Muscular Atrophy] at the CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS - National Commission for the Incorporation of Technologies in the SUS (Brazilian Public Health System)] meeting held in December 2025; submission of responses and recommendations to CONITEC's preliminary reports on the reimbursement of SMA treatments; and mobilisation of public participation in open consultations. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 5000 | National | Regularly | 119042861822 |
| Our activities encompass advocacy, participation in meetings, submission of formal correspondence, and community mobilisation in public consultations. | Disabilità > Disabilità: giovani | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | National | Regularly | 119047401612 |
| Public hearings. | Cancro > Cancro: seno | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | Local | Regularly | 119052436713 |
| The most recent public consultations on medicines related to the treatment of breast cancer attracted participation both from individuals — patients and caregivers — within our sphere of influence, as well as formal institutional engagement. | Cancro > Cancro: seno | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | Regional | Regularly | 119063227678 |
| By raising awareness and educating patients, we work to ensure that public authorities recognise the full complexity of this disease. We encourage broad participation in the public consultations held on the condition, and advocate for access to new therapies — including high-cost medications and complementary treatments — with the overarching goal of making all available treatments accessible through the SUS [Sistema Único de Saúde, Brazil's unified public health system]. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | Not specified | Local | Regularly | 119072244093 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged in ... The participation in public hearings and technical meetings with governmental bodies and institutions within the health system. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 10.000 | National | Regularly | 119073066358 |
| The organisation participates actively in public hearings held by the ANS (Agência Nacional de Saúde Suplementar — Brazil's National Supplementary Health Agency) and the National Congress, as well as in public consultations convened by the ANS and CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS — National Committee for Health Technology Incorporation in the Unified Health System), and contributes to the National Health Council through the seat held by Biored Brasil, an organization co-founded by AME [Amigos Múltiplos pela Esclerose - Multiple Friends for Sclerosis] , among others. The organisation further acts as a proponent of solutions it considers to be structural in nature, directing strategies that connect all of the aforementioned bodies through the drafting of legislative bills, technical briefs, and supplementary documents intended to support — within AME's remit — the Health Technology Assessment (HTA) process in Brazil. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 100.000 | National | Regularly | 119073437945 |
| Our engagement spans from participation in public consultations — including those conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. Our social oversight and mobilisation efforts are conducted strategically and also include direct engagement with regulatory authorities. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 100.000 | National | Regularly | 119074690047 |
| Activities range from participation in public consultations held by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and the ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 100.000 | National | Regularly | 119074690047 |
| Through our presence in Brasília — engaging with health authorities and the National Congress in the development and defence of public health policies. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 5000 | National | Regularly | 119074846445 |
| Public hearings and meetings with health secretariats. | Cronico > Malattie croniche in generale | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 5000 | National | Regularly | 119074863856 |
| By participating in public consultations. | Sanguinamento > Disturbi emorragici: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | Regional | Sometimes | 119077025336 |
| Through advocacy activities, public consultations, public hearings, and social media. | Cancro > Cancro: seno | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 100 | National | Regularly | 119077684629 |
| We have participated as speakers at public hearings on disease treatment. | Reumatico > Lupus | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 100 | National | Regularly | 119077822580 |
| ... We are actively engaged in public consultations [in Brazil] in the interests of patients. | Cancro > Cancro: sangue | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 10.000 | National | Regularly | 119078150255 |
| ANNABRA — Associação Nanismo Brasil (Brazilian Dwarfism Association) — represents the interests of individuals living with dwarfism and their families across a range of institutional settings and public policy forums. The association participates in public consultations and monitors health technology assessment (HTA) processes conducted by the regulatory bodies responsible for recommendations on the reimbursement and access to medicines. In addition, ANNABRA maintains active dialogue and engagement with the National Congress, parliamentary caucuses, state legislative chambers, legislative assemblies, and health councils and bodies linked to public health. Through these channels, the association contributes technical information, family testimonies, and evidence on the needs of the dwarfism community — particularly on issues relating to access to treatments, specialist follow-up care, and health policies for conditions such as achondroplasia. | Endocrino > Disturbi della crescita | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | National | Regularly | 119078211127 |
| We participate in public consultations and meetings with political representatives, articulating our demands on this issue and the contribution it can make to the broader policy agenda. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 5000 | National | Regularly | 119078218520 |
| We hold seats on the CNS [Conselho Nacional de Saúde - National Health Council], coordinating the CICTAF [Comissão Intersetorial de Ciência, Tecnologia e Assistência Farmacêutica - Intersectoral Committee on Science, Technology, and Health Innovation] and other standing committees. We are also represented on CONADE [Conselho Nacional dos Direitos da Pessoa com Deficiência – National Council for the Rights of Persons with Disabilities], where we sit on the public policy commission, and we participate in various other committees and councils. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | National | Regularly | 119078307187 |
| We participate actively in decision-making bodies, conducting advocacy work with the legislature and government secretariats. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 5000 | National | Regularly | 119045358161 |
| Direct engagement with members of the Chamber of Deputies and the Senate [in Brazil] serving on the rare diseases committee. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 100 | National | Regularly | 119051551373 |
| Participation in councils and forums; endorsement of position statements; mobilisation of parliamentarians; submission of legislative proposals and regulatory recommendations; and engagement of public opinion and regulatory authorities. | Sanguinamento > Emofilia | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 1000 | Regional | Regularly | 119052656211 |
| We work alongside legislators to drive improvements and advance bills that serve the interests of patients. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 1000 | National | Regularly | 119072208647 |
| Our engagement spans from participation in public consultations — including those conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. Our social oversight and mobilisation efforts are conducted strategically and also include direct engagement with regulatory authorities. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 100.000 | National | Regularly | 119074690047 |
| … and working alongside members of the Chamber of Deputies and the Senate to advance dedicated legislation. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 5000 | National | Regularly | 119074846445 |
| ANNABRA — Associação Nanismo Brasil (Brazilian Dwarfism Association) — represents the interests of individuals living with dwarfism and their families across a range of institutional settings and public policy forums. The association participates in public consultations and monitors health technology assessment (HTA) processes conducted by the regulatory bodies responsible for recommendations on the reimbursement and access to medicines. In addition, ANNABRA maintains active dialogue and engagement with the National Congress, parliamentary caucuses, state legislative chambers, legislative assemblies, and health councils and bodies linked to public health. | Endocrino > Disturbi della crescita | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 1000 | National | Regularly | 119078211127 |
| We participate in public consultations and meetings with political representatives, articulating our demands on this issue and the contribution it can make to the broader policy agenda. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Mobilitare parlamentari e leader politici | 5000 | National | Regularly | 119078218520 |
| Public policies pertaining to patient rights. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Sostenere le leggi e i diritti per la protezione dei pazienti | 1000 | Regional | Regularly | 119077889187 |
| The inclusion of AME [Atrofia Muscular Espinhal – Spinal Muscular Atrophy] in the expanded newborn screening programme [newborn heel-prick screening programme], under Brazilian Federal Law 14,154/2021, together with the relevant legislation at the municipal level in Curitiba and across the state of Paraná — and now its full implementation in Paraná. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 100 | National | Regularly | 119012383199 |
| By participating in the development of public policies. | Neurodegenerativo > Alzheimer | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 5000 | National | Regularly | 119037286447 |
| Implementation of neonatal screening in the state of Paraná [Brazil]; implementation of Law No. 14.154/2021. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 100 | National | Regularly | 119052447696 |
| Participation in councils and forums; endorsement of position statements; mobilisation of parliamentarians; submission of legislative proposals and regulatory recommendations; and engagement of public opinion and regulatory authorities. | Sanguinamento > Emofilia | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 1000 | Regional | Regularly | 119052656211 |
| The organization participates actively in public hearings held by the ANS (Agência Nacional de Saúde Suplementar — Brazil's National Supplementary Health Agency) and the National Congress, as well as in public consultations convened by the ANS and CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS — National Committee for Health Technology Incorporation in the Unified Health System), and contributes to the National Health Council through the seat held by Biored Brasil, an organization co-founded by AME [Amigos Múltiplos pela Esclerose - Multiple Friends for Sclerosis] , among others. The organiSation further acts as a proponent of solutions it considers to be structural in nature, directing strategies that connect all of the aforementioned bodies through the drafting of legislative bills, technical briefs, and supplementary documents intended to support — within AME's remit — the Health Technology Assessment (HTA) process in Brazil. | Neurologico > Sclerosi multipla | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 100.000 | National | Regularly | 119073437945 |
| … and working alongside members of the Chamber of Deputies and the Senate to advance dedicated legislation. | Raro > Malattie rare: la maggior parte dei tipi | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 5000 | National | Regularly | 119074846445 |
| We have participated as speakers in public hearings on disease treatment and have been involved in the drafting of public health legislation. | Reumatico > Lupus | Influenzare le politiche e la legislazione > Contribuire alla redazione della legislazione in materia di salute pubblica | 100 | National | Regularly | 119077822580 |
| We have already approached manufacturers seeking a social pricing scheme, without success. | HIV > HIV | Advocacy per prezzi e accessibilità economica > Sostenere prezzi equi dei farmaci | 10.000 | Local | Sometimes | 119072634823 |
| Ensuring access for patients who cannot afford treatment in the context of reimbursement and coverage decisions. | Salute generale > Salute pubblica | Advocacy per prezzi e accessibilità economica > Sostenere prezzi equi dei farmaci | We do not communicate with patients directly | National | Rarely | 119073385147 |
| We are responsible for facilitating a transfer mechanism to reduce the cost of advanced therapies in the country [Brazil]. | Raro > Malattie rare: la maggior parte dei tipi | Advocacy per prezzi e accessibilità economica > Sostenere prezzi equi dei farmaci | 10.000 | National | Rarely | 119078192576 |
| Ensuring access for patients who cannot afford treatment in the context of reimbursement and coverage decisions. | Salute generale > Salute pubblica | Advocacy per prezzi e accessibilità economica > Affrontare le barriere di costo per le persone a basso reddito e vulnerabili | We do not communicate with patients directly | National | Rarely | 119073385147 |
| Position statement on the shortage of Hydroxyurea [chemotherapy to treat some blood cancers] within Brazil's public healthcare network for the treatment of these patients. | Sangue > Malattia falciforme | Advocacy per prezzi e accessibilità economica > Monitoraggio e tracciamento dei prezzi dei farmaci/carenze di farmaci | 5000 | National | Regularly | 119069254783 |
| We have already approached manufacturers seeking a social pricing scheme, without success. | HIV > HIV | Advocacy per prezzi e accessibilità economica > Monitoraggio e tracciamento dei prezzi dei farmaci/carenze di farmaci | 10.000 | Local | Sometimes | 119072634823 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged in collaboration with the Public Prosecutor's Office, Public Defenders' Offices, and other social oversight bodies in cases of access difficulties or medicine supply shortages. | Neurologico > Sclerosi multipla | Advocacy per prezzi e accessibilità economica > Monitoraggio e tracciamento dei prezzi dei farmaci/carenze di farmaci | 10.000 | National | Regularly | 119073066358 |
| We are responsible for facilitating a transfer mechanism to reduce the cost of advanced therapies in the country [Brazil]. | Raro > Malattie rare: la maggior parte dei tipi | Advocacy per prezzi e accessibilità economica > Monitoraggio della sostituzione del prodotto | 10.000 | National | Rarely | 119078192576 |
| Participating in the development of public policies and in meetings concerning the incorporation of medicines. | Neurodegenerativo > Alzheimer | Advocacy per prezzi e accessibilità economica > Sostenere l'inclusione del prodotto negli elenchi di rimborso/formulari nazionali | 5000 | National | Regularly | 119037286447 |
| Participation in debates on the incorporation of therapies into the SUS [Sistema Único de Saúde – Unified Health System]. | Disabilità visiva > Disabilità visiva | Advocacy per prezzi e accessibilità economica > Sostenere l'inclusione del prodotto negli elenchi di rimborso/formulari nazionali | 1000 | National | Regularly | 119065385473 |
| Yes, in the reimbursement incorporation processes for the three medicines indicated for AME [Atrofia Muscular Espinhal – Spinal Muscular Atrophy]. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Advocacy per prezzi e accessibilità economica > Sostenere l'inclusione del prodotto negli elenchi di rimborso/formulari nazionali | 100 | Regional | Regularly | 119071788857 |
| By raising awareness and educating patients, we work to ensure that public authorities recognise the full complexity of this disease. We encourage broad participation in the public consultations held on the condition, and advocate for access to new therapies — including high-cost medications and complementary treatments — with the overarching goal of making all available treatments accessible through the SUS [Sistema Único de Saúde, Brazil's unified public health system]. | Neurologico > Sclerosi multipla | Advocacy per prezzi e accessibilità economica > Sostenere l'inclusione del prodotto negli elenchi di rimborso/formulari nazionali | Not specified | Local | Regularly | 119072244093 |
| Ensuring access for patients who cannot afford treatment in the context of reimbursement and coverage decisions. | Salute generale > Salute pubblica | Advocacy per prezzi e accessibilità economica > Sostenere l'inclusione del prodotto negli elenchi di rimborso/formulari nazionali | We do not communicate with patients directly | National | Rarely | 119073385147 |
| We run campaigns advocating for the inclusion of medicines in the SUS [Sistema Único de Saúde – Unified Health System]. | Cancro > Cancro: seno | Advocacy per prezzi e accessibilità economica > Sostenere l'inclusione del prodotto negli elenchi di rimborso/formulari nazionali | 100 | Local | Sometimes | 119078637202 |
| By raising awareness and educating patients, we work to ensure that public authorities recognise the full complexity of this disease. We encourage broad participation in the public consultations held on the condition, and advocate for access to new therapies — including high-cost medications and complementary treatments — with the overarching goal of making all available treatments accessible through the SUS [Sistema Único de Saúde, Brazil's unified public health system]. | Neurologico > Sclerosi multipla | Advocacy per prezzi e accessibilità economica > Partecipare a campagne di sensibilizzazione | Not specified | Local | Regularly | 119072244093 |
| Public policies concerning patient rights, including state-level awareness campaigns [on issues of drug pricing]. | Neurologico > Sclerosi multipla | Advocacy per prezzi e accessibilità economica > Partecipare a campagne di sensibilizzazione | 1000 | Regional | Regularly | 119077889187 |
| Not necessarily with respect to pricing; however, when required, we engage with public authorities to ensure that patients receive the medication prescribed by their physician, regardless of whether it is low- or high-cost. | Neuromuscolare > Miastenia grave | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 1000 | National | Rarely | 119020326698 |
| Regarding access to treatments and medicines. | Sanguinamento > Emofilia | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 100 | Local | Regularly | 119050022800 |
| We advocate for public policies, access, treatment, updates, and so forth. | Raro > Malattie rare: la maggior parte dei tipi | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 5000 | National | Regularly | 119055145819 |
| Position statement on the shortage of Hydroxyurea [chemotherapy to treat some blood cancers] within Brazil's public healthcare network for the treatment of these patients. | Sangue > Malattia falciforme | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 5000 | National | Sometimes | 119068055140 |
| By raising awareness and educating patients, we work to ensure that public authorities recognise the full complexity of this disease. We encourage broad participation in the public consultations held on the condition, and advocate for access to new therapies — including high-cost medications and complementary treatments — with the overarching goal of making all available treatments accessible through the SUS [Sistema Único de Saúde, Brazil's unified public health system]. | Neurologico > Sclerosi multipla | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | Not specified | Local | Regularly | 119072244093 |
| ABEM (Associação Brasileira de Esclerose Múltipla — the Brazilian Multiple Sclerosis Association) plays an active role in the institutional representation of people living with multiple sclerosis in Brazil, engaging with regulatory bodies, government authorities, and public policy forums on issues related to treatment access. In this capacity, the organisation participates in a range of advocacy and institutional engagement activities, including: • preparation of technical notes, formal institutional correspondence, and official position statements in support of equitable access to treatments; policies. | Neurologico > Sclerosi multipla | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 10.000 | National | Regularly | 119073066358 |
| The organisation advocates for the rights of patients living with rheumatic and autoimmune diseases, providing guidance on access to treatments through the SUS [Sistema Única de Saúde – Unified Health System], facilitating dialogue with healthcare professionals, and supporting awareness initiatives and public policy efforts focused on patient needs. | Reumatico > Malattie reumatiche: la maggior parte dei tipi | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 1000 | Local | Sometimes | 119074685227 |
| We maintain partnerships with the Public Prosecutor's Office, the Public Defender's Office, the State Department of Health, municipal health secretariats, and other institutions that can support the procurement and/or approval of medications. | Raro > Malattie rare: la maggior parte dei tipi | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 10.000 | Regional | Sometimes | 119077778824 |
| We are responsible for facilitating a transfer mechanism to reduce the cost of advanced therapies in the country [Brazil]. | Raro > Malattie rare: la maggior parte dei tipi | Miglioramento dei percorsi di accesso > Facilitare l'accesso equo ai medicinali/all'assistenza sanitaria | 10.000 | National | Rarely | 119078192576 |
| The inclusion of AME [Atrofia Muscular Espinhal – Spinal Muscular Atrophy] in the expanded newborn screening programme [newborn heel-prick screening programme], under Brazilian Federal Law 14,154/2021, together with the relevant legislation at the municipal level in Curitiba and across the state of Paraná — and now its full implementation in Paraná. | Raro > Malattie rare: la maggior parte dei tipi | Miglioramento dei percorsi di accesso > Affrontare le disparità nell'accesso e nella gestione | 100 | National | Regularly | 119012383199 |
| Implementation of neonatal screening in the state of Paraná [Brazil]; implementation of Law No. 14.154/2021. | Raro > Malattie rare: la maggior parte dei tipi | Miglioramento dei percorsi di accesso > Affrontare le disparità nell'accesso e nella gestione | 100 | National | Regularly | 119052447696 |
| Position statement on the shortage of Hydroxyurea [chemotherapy to treat some blood cancers] within Brazil's public healthcare network for the treatment of these patients. | Sangue > Malattia falciforme | Miglioramento dei percorsi di accesso > Affrontare le disparità nell'accesso e nella gestione | 5000 | National | Regularly | 119069254783 |
| Direct engagement with members of the Chamber of Deputies and the Senate [in Brazil] serving on the rare diseases committee. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Miglioramento dei percorsi di accesso > Miglioramento dell'accesso alle terapie rare/ultra-rare | 100 | National | Regularly | 119051551373 |
| Direct meetings with the division of the Ministry of Health responsible for rare disease care. | Neuromuscolare > Atrofia muscolare spinale (SMA) | Miglioramento dei percorsi di accesso > Miglioramento dell'accesso alle terapie rare/ultra-rare | 100 | National | Regularly | 119051551373 |
| We are active in discussions on the incorporation of therapies into the SUS (Sistema Único de Saúde — Brazil's Unified Health System), access to high-cost medicines, participation in ATS [Avaliação de Tecnologias em Saúde – Health Technology Assessment] deliberations, and the judicialization of rare disease treatment access [the growing phenomenon of patients and advocacy groups turning to the courts to mandate state or private insurers to cover treatment costs]. | Disabilità visiva > Disabilità visiva | Miglioramento dei percorsi di accesso > Miglioramento dell'accesso alle terapie rare/ultra-rare | 1000 | National | Regularly | 119065385473 |
| Although ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] does not participate directly in medicine pricing decisions — which in Brazil are conducted by CMED [Câmara de Regulação do Mercado de Medicamentos – Chamber for Medicines Market Regulation] — the organisation contributes to the public and institutional debate on treatment access, availability, and sustainability, bringing the perspective of people living with multiple sclerosis and their families. | Neurologico > Sclerosi multipla | Contributo del paziente basato sull'evidenza > Utilizza le informazioni sui pazienti per prendere decisioni informate | 10.000 | National | Regularly | 119073066358 |
| Advocacy meetings on behalf of therapies, presenting an up-to-date overview of the Brazilian landscape and real-world evidence. | Neuromuscolare > Distrofia muscolare | Contributo del paziente basato sull'evidenza > Utilizza le informazioni sui pazienti per prendere decisioni informate | 1000 | National | Regularly | 119077508858 |
| Advocacy meetings on behalf of therapies, presenting an up-to-date overview of the Brazilian landscape and real-world evidence. | Neuromuscolare > Distrofia muscolare | Contributo del paziente basato sull'evidenza > Fornire prove del mondo reale (RWE) alle agenzie regolatorie | 1000 | National | Regularly | 119077508858 |
| We contribute to the public consultations conducted by CONITEC (Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde — Brazil's national health technology assessment body) in the oncology area, doing so through FEMAMA (Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama). We frequently register patients to provide their firsthand experiences with specific treatments or new health technologies under review. | Cancro > Cancro: la maggior parte dei tipi | Contributo del paziente basato sull'evidenza > Sfrutta le storie dei pazienti e le narrazioni basate sull'esperienza vissuta | 10.000 | Local | Rarely | 119042830466 |
| ANNABRA — Associação Nanismo Brasil (Brazilian Dwarfism Association) — represents the interests of individuals living with dwarfism and their families across a range of institutional settings and public policy forums. The association participates in public consultations and monitors health technology assessment (HTA) processes conducted by the regulatory bodies responsible for recommendations on the reimbursement and access to medicines. In addition, ANNABRA maintains active dialogue and engagement with the National Congress, parliamentary caucuses, state legislative chambers, legislative assemblies, and health councils and bodies linked to public health. Through these channels, the association contributes technical information, family testimonies, and evidence on the needs of the dwarfism community — particularly on issues relating to access to treatments, specialist follow-up care, and health policies for conditions such as achondroplasia. This work aims to strengthen civil society participation in decision-making processes and to advance broader understanding of the specific needs of individuals living with dwarfism in Brazil. | Endocrino > Disturbi della crescita | Contributo del paziente basato sull'evidenza > Sfrutta le storie dei pazienti e le narrazioni basate sull'esperienza vissuta | 1000 | National | Regularly | 119078211127 |
| Participation in scientific medical congresses and research. | Endocrino > Disturbi della crescita | Contributo del paziente basato sull'evidenza > Condurre sondaggi/ricerche per generare dati | 1000 | National | Regularly | 119078198577 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged in ... drafting technical position papers, formal institutional correspondence, and official statements in support of equitable access to treatments. | Neurologico > Sclerosi multipla | Contributo del paziente basato sull'evidenza > Tradurre prove e approfondimenti in contributi politici | 10.000 | National | Regularly | 119073066358 |
| ANNABRA — Associação Nanismo Brasil (Brazilian Dwarfism Association) —maintains active dialogue and engagement with the National Congress, parliamentary caucuses, state legislative chambers, legislative assemblies, and health councils and bodies linked to public health. Through these channels, the association contributes technical information, family testimonies, and evidence on the needs of the dwarfism community — particularly on issues relating to access to treatments, specialist follow-up care, and health policies for conditions such as achondroplasia. This work aims to strengthen civil society participation in decision-making processes and to advance broader understanding of the specific needs of individuals living with dwarfism in Brazil. | Endocrino > Disturbi della crescita | Contributo del paziente basato sull'evidenza > Tradurre prove e approfondimenti in contributi politici | 1000 | National | Regularly | 119078211127 |
| The inclusion of AME [Atrofia Muscular Espinhal – Spinal Muscular Atrophy] in the expanded newborn screening programme [newborn heel-prick screening programme], under Brazilian Federal Law 14,154/2021, together with the relevant legislation at the municipal level in Curitiba and across the state of Paraná — and now its full implementation in Paraná. | Raro > Malattie rare: la maggior parte dei tipi | Diagnosi e consegna dei medicinali > Supporto allo screening e alla diagnosi precoce | 100 | National | Regularly | 119012383199 |
| Implementation of newborn screening in the state of Paraná. | Raro > Malattie rare: la maggior parte dei tipi | Diagnosi e consegna dei medicinali > Supporto allo screening e alla diagnosi precoce | 100 | National | Regularly | 119052447696 |
| Both within representative bodies and among regulators such as CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation]. | Cancro > Cancro: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100 | National | Sometimes | 115043432408 |
| We hold seats on the Municipal Health Council of Salvador, the State Health Council of Bahia, and the National Health Council, through FEMAMA [Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama – Brazilian Federation of Philanthropic Institutions Supporting Breast Health]. | Cancro > Cancro: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 5000 | Local | Regularly | 119021005578 |
| Ministry of Health, ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency], CNS [Conselho Nacional de Saúde – National Health Council], Conass [Conselho Nacional de Secretários de Saúde – National Council of State Health Secretaries], Canasems [Conselho Nacional de Secretarias Municipais de Saúde – National Council of Municipal Health Secretaries]. | Endocrino > Diabete (sia di tipo 1 che di tipo 2) | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 10.000 | Regional | Regularly | 119044579058 |
| Engagement with ANVISA [Agência Nacional de Vigilância Sanitária – National Health Surveillance Agency] and CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], through the commissions of the National Health Council, on behalf of ADB [Associação de Doentes de Behçet - Behçet’s Disease Patients Association]. | Neuromuscolare > Distrofia muscolare | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100 | Regional | Regularly | 119045134485 |
| We participate actively in decision-making bodies, conducting advocacy work with the legislature and government secretariats. | Raro > Malattie rare: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 5000 | National | Regularly | 119045358161 |
| Our organisation is a member of the Advisory Board of INCA [Instituto Nacional de Câncer – National Cancer Institute] (CONSINCA [Conselho Consultivo do INCA – Advisory Board of INCA]), CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], and COSAÚDE [Comitê de Saúde Suplementar -Supplementary Health Committee]. | Cancro > Cancro: sangue | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 10.000 | National | Regularly | 119046062542 |
| We are members of the State Advocacy Commission. | Cancro > Cancro: seno | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100 | Local | Regularly | 119052625607 |
| Participation in advisory councils, forums, and public manifestos. | Sanguinamento > Emofilia | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 1000 | Regional | Regularly | 119052656211 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged in the institutional representation of people living with multiple sclerosis in Brazil, maintaining dialogue with regulatory bodies, governmental authorities, and forums involved in the formulation of public policies related to treatment access. | Neurologico > Sclerosi multipla | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 10.000 | National | Regularly | 119073066358 |
| The organization participates actively in public hearings held by the ANS (Agência Nacional de Saúde Suplementar — Brazil's National Supplementary Health Agency) and the National Congress, as well as in public consultations convened by the ANS and CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS — National Committee for Health Technology Incorporation in the Unified Health System), and contributes to the National Health Council through the seat held by Biored Brasil, an organization co-founded by AME [Amigos Múltiplos pela Esclerose - Multiple Friends for Sclerosis] , among others. The organiSation further acts as a proponent of solutions it considers to be structural in nature, directing strategies that connect all of the aforementioned bodies through the drafting of legislative bills, technical briefs, and supplementary documents intended to support — within AME's remit — the Health Technology Assessment (HTA) process in Brazil. | Neurologico > Sclerosi multipla | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100.000 | National | Regularly | 119073437945 |
| … To effective representation through a formal presence within the CNS [Conselho Nacional de Saúde – National Health Council]. | Cronico > Malattie croniche in generale | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100.000 | National | Regularly | 119074690098 |
| Our engagement spans from participation in public consultations — including those conducted by CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation] and ANS [Agência Nacional de Saúde Suplementar – National Supplementary Health Agency]. Our social oversight and mobilisation efforts are conducted strategically and also include direct engagement with regulatory authorities. | Cronico > Malattie croniche in generale | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100.000 | National | Regularly | 119074690098 |
| We hold seats on the ONGs [Organizações Não Governamentais – Non-Governmental Organisations] AIDS [Acquired immunodeficiency syndrome] Forum of the State of São Paulo, the Municipal Health Secretariat of São Paulo–SP [State of São Paulo], the CTA [Centro de Testagem e Aconselhamento - Testing and Counselling Centre]-Pirituba Management Council, the Paulistano Movement in the Fight Against AIDS, and the Human Rights Council of the State Secretariat of Justice – SP[State of São Paulo]. | HIV > HIV | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 1000 | National | Regularly | 119074698753 |
| Yes, we hold seats on health councils and health agencies. | Cancro > Cancro: sangue | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 10.000 | National | Regularly | 119078150255 |
| We hold seats on the CNS [Conselho Nacional de Saúde - National Health Council], coordinating the CICTAF [Comissão Intersetorial de Ciência, Tecnologia e Assistência Farmacêutica - Intersectoral Committee on Science, Technology, and Health Innovation] and other standing committees. We are also represented on CONADE [Conselho Nacional dos Direitos da Pessoa com Deficiência – National Council for the Rights of Persons with Disabilities], where we sit on the public policy commission, and we participate in various other committees and councils. | Raro > Malattie rare: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 1000 | National | Regularly | 119078307187 |
| We hold seats on the CNS [Conselho Nacional de Saúde – National Health Council] and serve on the coordinating body of the CICTAF [Comissão Intersetorial de Ciência, Tecnologia e Assistência Farmacêutica - Intersectoral Commission on Science, Technology and Pharmaceutical Assistance], as well as other commissions. | Raro > Malattie rare: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 1000 | National | Regularly | 119078307187 |
| The organisation to which I belong holds a seat on the Conselho Nacional de Saúde [National Health Council]. | Raro > Malattie rare: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 10.000 | National | Regularly | 119078420142 |
| We engage with government bodies in forums where matters relating to our cause are discussed. | Sanguinamento > Disturbi emorragici: la maggior parte dei tipi | Governance istituzionale > Garantire la rappresentanza negli organi consultivi governativi | 100.000 | National | Regularly | 119083316815 |
| Meetings with organisations operating at the same level. | Reumatico > Malattie reumatiche: la maggior parte dei tipi | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 100 | Local | Sometimes | 119014521397 |
| Our organisation is a member of the Advisory Board of INCA [Instituto Nacional de Câncer – National Cancer Institute] (CONSINCA [Conselho Consultivo do INCA – Advisory Board of INCA]), CONITEC [Comissão Nacional de Incorporação de Tecnologias no SUS – National Committee for Health Technology Incorporation], and COSAÚDE [Comitê de Saúde Suplementar -Supplementary Health Committee]. | Cancro > Cancro: sangue | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 10.000 | National | Regularly | 119046062542 |
| Our activities encompass advocacy, participation in meetings, submission of formal correspondence, and community mobilisation in public consultations. | Disabilità > Disabilità: giovani | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 1000 | National | Regularly | 119047401612 |
| ABEM (Associação Brasileira de Esclerose Múltipla — the Brazilian Multiple Sclerosis Association) plays an active role in the institutional representation of people living with multiple sclerosis in Brazil, engaging with regulatory bodies, government authorities, and public policy forums on issues related to treatment access. In this capacity, the organisation participates in a range of advocacy and institutional engagement activities, including: • collaboration with other civil society organisations, patient networks, and subject-matter experts to strengthen the collective representation of the interests of people living with demyelinating diseases. | Neurologico > Sclerosi multipla | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 10.000 | National | Regularly | 119073066358 |
| ABEM [Associação Brasileira de Esclerose Múltipla -Brazilian Multiple Sclerosis Association] is actively engaged … in the coordination with other civil society organisations, patient networks, and subject-matter experts to strengthen the collective representation of the interests of people living with demyelinating diseases. | Neurologico > Sclerosi multipla | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 10.000 | National | Regularly | 119073066358 |
| We hold seats on the ONGs [Organizações Não Governamentais – Non-Governmental Organisations] AIDS [Acquired immunodeficiency syndrome] Forum of the State of São Paulo, the Municipal Health Secretariat of São Paulo–SP [State of São Paulo], the CTA [Centro de Testagem e Aconselhamento - Testing and Counselling Centre]-Pirituba Management Council, the Paulistano Movement in the Fight Against AIDS, and the Human Rights Council of the State Secretariat of Justice – SP[State of São Paulo]. | HIV > HIV | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 1000 | National | Regularly | 119074698753 |
| We maintain partnerships with the Public Prosecutor's Office, the Public Defender's Office, the State Department of Health, municipal health secretariats, and other institutions that can support the procurement and/or approval of medications. | Raro > Malattie rare: la maggior parte dei tipi | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 10.000 | Regional | Sometimes | 119077778824 |
| Participation in scientific medical congresses and research. | Endocrino > Disturbi della crescita | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 1000 | National | Regularly | 119078198577 |
| ANNABRA — Associação Nanismo Brasil (Brazilian Dwarfism Association) — represents the interests of individuals living with dwarfism and their families across a range of institutional settings and public policy forums. The association participates in public consultations and monitors health technology assessment (HTA) processes conducted by the regulatory bodies responsible for recommendations on the reimbursement and access to medicines. In addition, ANNABRA maintains active dialogue and engagement with the National Congress, parliamentary caucuses, state legislative chambers, legislative assemblies, and health councils and bodies linked to public health. Through these channels, the association contributes technical information, family testimonies, and evidence on the needs of the dwarfism community — particularly on issues relating to access to treatments, specialist follow-up care, and health policies for conditions such as achondroplasia. This work aims to strengthen civil society participation in decision-making processes and to advance broader understanding of the specific needs of individuals living with dwarfism in Brazil. | Endocrino > Disturbi della crescita | Governance istituzionale > Lavorare efficacemente all'interno di reti multi-stakeholder | 1000 | National | Regularly | 119078211127 |
| The organisation advocates for the rights of patients living with rheumatic and autoimmune diseases, providing guidance on access to treatments through the SUS [Sistema Única de Saúde – Unified Health System], facilitating dialogue with healthcare professionals, and supporting awareness initiatives and public policy efforts focused on patient needs. | Reumatico > Malattie reumatiche: la maggior parte dei tipi | Tutela dei diritti dei pazienti/miglioramento della qualità della vita > Proteggere/migliorare l'esperienza del paziente | 1000 | Local | Sometimes | 119074685227 |
| Educating patients on how to assert their rights when necessary. | Raro > Malattie rare: metaboliche/lisosomiali | Tutela dei diritti dei pazienti/miglioramento della qualità della vita > Proteggere/migliorare l'esperienza del paziente | 1000 | National | Sometimes | 119075128442 |
| We are active in discussions on the incorporation of therapies into the SUS (Sistema Único de Saúde — Brazil's Unified Health System), access to high-cost medicines, participation in ATS [Avaliação de Tecnologias em Saúde – Health Technology Assessment] deliberations, and the judicialization of rare disease treatment access [the growing phenomenon of patients and advocacy groups turning to the courts to mandate state or private insurers to cover treatment costs]. | Disabilità visiva > Disabilità visiva | Tutela dei diritti dei pazienti/miglioramento della qualità della vita > Supporto nelle azioni legali correlate al trattamento | 1000 | National | Regularly | 119065385473 |
SCARICA IL REPORT
La nostra ricerca copre 2.262 gruppi di pazienti che rappresentano 100 paesi e 45 aree terapeutiche. Il report campione mostra la profondità dell'analisi per un singolo paese o area terapeutica. Per accedere a qualsiasi altro report, si prega di contattarci.
Visita patient-view.com per raccogliere ulteriori informazioni o invia un'email a: Alex Wyke, alexwyke@patient-view.com